CCR5 and atherosclerosis: Monocyte recruitment and subsequent atherosclerosis in ApoE−/− mice are also reduced by inhibiting the chemoattractants CCL2, CXCR1, CCR5, and M-CSF, either by pharmacological blockade [60] or genetic inactivation [4,84].